Search research articles
Contact Us
Filters
Showing results (91-100 of 148) with videos related to
Page
of 15
Sort By:
Haematologica
|
March 7, 2024
Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases
Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, et al.
Leukemia & Lymphoma
|
August 27, 2021
Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis
Rami Komrokji, Megan Melody, Najla Al Ali, et al.
British Journal of Haematology
|
August 4, 2021
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases
Kebede H Begna, Jaya Kittur, Jennifer Yui, et al.
British Journal of Haematology
|
May 5, 2023
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms
Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, et al.
Cell Death & Disease
|
November 7, 2025
The RNA N<sup>6</sup>-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signaling
Yanhong Tan, Changli Zhou, Sicheng Bian, et al.
Leukemia & Lymphoma
|
October 24, 2012
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy
Ming Y Lim, Aref Al-Kali, Aneel A Ashrani, et al.
American Journal of Hematology
|
September 27, 2024
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis
Ayalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, et al.
Cancer
|
March 19, 2016
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies
Gautam Borthakur, Leslie Popplewell, Michael Boyiadzis, et al.
Blood Cancer Journal
|
March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
American Journal of Clinical Pathology
|
May 12, 2021
Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations
Elise R Venable, Dong Chen, Constance P Chen, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 148) with videos related to
Sort By:
Page
of 15
Haematologica
|
March 7, 2024
Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases
Faiqa Farrukh, Maymona Abdelmagid, Abhishek Mangaonkar, et al.
Leukemia & Lymphoma
|
August 27, 2021
Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis
Rami Komrokji, Megan Melody, Najla Al Ali, et al.
British Journal of Haematology
|
August 4, 2021
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases
Kebede H Begna, Jaya Kittur, Jennifer Yui, et al.
British Journal of Haematology
|
May 5, 2023
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms
Mark Gurney, Ismahene Chekkaf, Anmol Baranwal, et al.
Cell Death & Disease
|
November 7, 2025
The RNA N<sup>6</sup>-methyladenosine methylome coordinates long non-coding RNAs to mediate cancer drug resistance by activating PI3K signaling
Yanhong Tan, Changli Zhou, Sicheng Bian, et al.
Leukemia & Lymphoma
|
October 24, 2012
Comparison of complication rates of Hickman(®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy
Ming Y Lim, Aref Al-Kali, Aneel A Ashrani, et al.
American Journal of Hematology
|
September 27, 2024
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis
Ayalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, et al.
Cancer
|
March 19, 2016
Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies
Gautam Borthakur, Leslie Popplewell, Michael Boyiadzis, et al.
Blood Cancer Journal
|
March 3, 2021
Mayo Clinic experience with 1123 adults with acute myeloid leukemia
Kebede H Begna, Walid Ali, Naseema Gangat, et al.
American Journal of Clinical Pathology
|
May 12, 2021
Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations
Elise R Venable, Dong Chen, Constance P Chen, et al.
Page
of 15